IQVIA HOLDINGS INC (QTS.DE) Fundamental Analysis & Valuation

FRA:QTS • US46266C1053

Current stock price

141.95 EUR
-0.75 (-0.53%)
Last:

This QTS.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. QTS.DE Profitability Analysis

1.1 Basic Checks

  • In the past year QTS was profitable.
  • In the past year QTS had a positive cash flow from operations.
  • In the past 5 years QTS has always been profitable.
  • QTS had a positive operating cash flow in each of the past 5 years.
QTS.DE Yearly Net Income VS EBIT VS OCF VS FCFQTS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

1.2 Ratios

  • QTS's Return On Assets of 4.54% is fine compared to the rest of the industry. QTS outperforms 61.11% of its industry peers.
  • With an excellent Return On Equity value of 20.91%, QTS belongs to the best of the industry, outperforming 94.44% of the companies in the same industry.
  • The Return On Invested Capital of QTS (8.79%) is better than 77.78% of its industry peers.
  • QTS had an Average Return On Invested Capital over the past 3 years of 8.91%. This is in line with the industry average of 9.03%.
Industry RankSector Rank
ROA 4.54%
ROE 20.91%
ROIC 8.79%
ROA(3y)4.91%
ROA(5y)4.59%
ROE(3y)21.92%
ROE(5y)20.14%
ROIC(3y)8.91%
ROIC(5y)8.09%
QTS.DE Yearly ROA, ROE, ROICQTS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • With a Profit Margin value of 8.34%, QTS perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
  • QTS's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 14.02%, QTS is in line with its industry, outperforming 44.44% of the companies in the same industry.
  • QTS's Operating Margin has improved in the last couple of years.
  • QTS's Gross Margin of 33.29% is on the low side compared to the rest of the industry. QTS is outperformed by 66.67% of its industry peers.
  • In the last couple of years the Gross Margin of QTS has remained more or less at the same level.
Industry RankSector Rank
OM 14.02%
PM (TTM) 8.34%
GM 33.29%
OM growth 3Y3.41%
OM growth 5Y15.26%
PM growth 3Y3.27%
PM growth 5Y27.69%
GM growth 3Y-1.55%
GM growth 5Y-0.4%
QTS.DE Yearly Profit, Operating, Gross MarginsQTS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. QTS.DE Health Analysis

2.1 Basic Checks

  • QTS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for QTS has been reduced compared to 1 year ago.
  • Compared to 5 years ago, QTS has less shares outstanding
  • Compared to 1 year ago, QTS has a worse debt to assets ratio.
QTS.DE Yearly Shares OutstandingQTS.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
QTS.DE Yearly Total Debt VS Total AssetsQTS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.2 Solvency

  • Based on the Altman-Z score of 1.77, we must say that QTS is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of QTS (1.77) is worse than 72.22% of its industry peers.
  • QTS has a debt to FCF ratio of 7.67. This is a slightly negative value and a sign of low solvency as QTS would need 7.67 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 7.67, QTS perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
  • A Debt/Equity ratio of 2.14 is on the high side and indicates that QTS has dependencies on debt financing.
  • QTS has a Debt to Equity ratio of 2.14. This is amonst the worse of the industry: QTS underperforms 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.14
Debt/FCF 7.67
Altman-Z 1.77
ROIC/WACC0.87
WACC10.09%
QTS.DE Yearly LT Debt VS Equity VS FCFQTS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.3 Liquidity

  • A Current Ratio of 0.75 indicates that QTS may have some problems paying its short term obligations.
  • QTS has a Current ratio of 0.75. This is amonst the worse of the industry: QTS underperforms 88.89% of its industry peers.
  • QTS has a Quick Ratio of 0.75. This is a bad value and indicates that QTS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • QTS has a worse Quick ratio (0.75) than 61.11% of its industry peers.
Industry RankSector Rank
Current Ratio 0.75
Quick Ratio 0.75
QTS.DE Yearly Current Assets VS Current LiabilitesQTS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. QTS.DE Growth Analysis

3.1 Past

  • QTS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.09%.
  • The Earnings Per Share has been growing by 13.19% on average over the past years. This is quite good.
  • The Revenue has been growing slightly by 5.87% in the past year.
  • Measured over the past years, QTS shows a small growth in Revenue. The Revenue has been growing by 7.50% on average per year.
EPS 1Y (TTM)7.09%
EPS 3Y5.46%
EPS 5Y13.19%
EPS Q2Q%9.62%
Revenue 1Y (TTM)5.87%
Revenue growth 3Y4.21%
Revenue growth 5Y7.5%
Sales Q2Q%10.26%

3.2 Future

  • QTS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.27% yearly.
  • QTS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.56% yearly.
EPS Next Y7.52%
EPS Next 2Y9.27%
EPS Next 3Y9.98%
EPS Next 5Y10.27%
Revenue Next Year6.51%
Revenue Next 2Y6.2%
Revenue Next 3Y6.17%
Revenue Next 5Y6.56%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
QTS.DE Yearly Revenue VS EstimatesQTS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
QTS.DE Yearly EPS VS EstimatesQTS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

6

4. QTS.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 13.93, QTS is valued correctly.
  • Based on the Price/Earnings ratio, QTS is valued a bit cheaper than 77.78% of the companies in the same industry.
  • QTS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.18.
  • With a Price/Forward Earnings ratio of 12.96, QTS is valued correctly.
  • QTS's Price/Forward Earnings ratio is rather cheap when compared to the industry. QTS is cheaper than 88.89% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of QTS to the average of the S&P500 Index (37.96), we can say QTS is valued rather cheaply.
Industry RankSector Rank
PE 13.93
Fwd PE 12.96
QTS.DE Price Earnings VS Forward Price EarningsQTS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 66.67% of the companies in the same industry are more expensive than QTS, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, QTS is valued cheaper than 88.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.61
EV/EBITDA 12.05
QTS.DE Per share dataQTS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • QTS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.85
PEG (5Y)1.06
EPS Next 2Y9.27%
EPS Next 3Y9.98%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. QTS.DE Dividend Analysis

5.1 Amount

  • QTS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

QTS.DE Fundamentals: All Metrics, Ratios and Statistics

IQVIA HOLDINGS INC

FRA:QTS (4/10/2026, 7:00:00 PM)

141.95

-0.75 (-0.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-05
Earnings (Next)05-04
Inst Owners103.46%
Inst Owner ChangeN/A
Ins Owners0.95%
Ins Owner ChangeN/A
Market Cap23.83B
Revenue(TTM)16.31B
Net Income(TTM)1.36B
Analysts83.87
Price Target210.16 (48.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.19%
Min EPS beat(2)-0.33%
Max EPS beat(2)-0.04%
EPS beat(4)2
Avg EPS beat(4)0.41%
Min EPS beat(4)-0.33%
Max EPS beat(4)1.56%
EPS beat(8)5
Avg EPS beat(8)0.54%
EPS beat(12)8
Avg EPS beat(12)0.59%
EPS beat(16)11
Avg EPS beat(16)0.76%
Revenue beat(2)1
Avg Revenue beat(2)0.75%
Min Revenue beat(2)-0.41%
Max Revenue beat(2)1.91%
Revenue beat(4)3
Avg Revenue beat(4)0.6%
Min Revenue beat(4)-0.41%
Max Revenue beat(4)1.91%
Revenue beat(8)3
Avg Revenue beat(8)0.19%
Revenue beat(12)5
Avg Revenue beat(12)0%
Revenue beat(16)6
Avg Revenue beat(16)-0.05%
PT rev (1m)-5.83%
PT rev (3m)-1.72%
EPS NQ rev (1m)0.02%
EPS NQ rev (3m)-4.37%
EPS NY rev (1m)0.09%
EPS NY rev (3m)-1.94%
Revenue NQ rev (1m)-0.05%
Revenue NQ rev (3m)0.39%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)1.06%
Valuation
Industry RankSector Rank
PE 13.93
Fwd PE 12.96
P/S 1.71
P/FCF 13.61
P/OCF 10.51
P/B 4.29
P/tB N/A
EV/EBITDA 12.05
EPS(TTM)10.19
EY7.18%
EPS(NY)10.95
Fwd EY7.72%
FCF(TTM)10.43
FCFY7.35%
OCF(TTM)13.5
OCFY9.51%
SpS82.96
BVpS33.08
TBVpS-76.68
PEG (NY)1.85
PEG (5Y)1.06
Graham Number87.09
Profitability
Industry RankSector Rank
ROA 4.54%
ROE 20.91%
ROCE 10.59%
ROIC 8.79%
ROICexc 9.76%
ROICexgc N/A
OM 14.02%
PM (TTM) 8.34%
GM 33.29%
FCFM 12.58%
ROA(3y)4.91%
ROA(5y)4.59%
ROE(3y)21.92%
ROE(5y)20.14%
ROIC(3y)8.91%
ROIC(5y)8.09%
ROICexc(3y)9.78%
ROICexc(5y)8.82%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.72%
ROCE(5y)9.74%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y5.87%
ROICexc growth 5Y22.13%
OM growth 3Y3.41%
OM growth 5Y15.26%
PM growth 3Y3.27%
PM growth 5Y27.69%
GM growth 3Y-1.55%
GM growth 5Y-0.4%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 2.14
Debt/FCF 7.67
Debt/EBITDA 4.05
Cap/Depr 52.71%
Cap/Sales 3.7%
Interest Coverage 3.53
Cash Conversion 77.35%
Profit Quality 150.81%
Current Ratio 0.75
Quick Ratio 0.75
Altman-Z 1.77
F-Score5
WACC10.09%
ROIC/WACC0.87
Cap/Depr(3y)54.81%
Cap/Depr(5y)54.94%
Cap/Sales(3y)3.98%
Cap/Sales(5y)4.25%
Profit Quality(3y)138.41%
Profit Quality(5y)159.78%
High Growth Momentum
Growth
EPS 1Y (TTM)7.09%
EPS 3Y5.46%
EPS 5Y13.19%
EPS Q2Q%9.62%
EPS Next Y7.52%
EPS Next 2Y9.27%
EPS Next 3Y9.98%
EPS Next 5Y10.27%
Revenue 1Y (TTM)5.87%
Revenue growth 3Y4.21%
Revenue growth 5Y7.5%
Sales Q2Q%10.26%
Revenue Next Year6.51%
Revenue Next 2Y6.2%
Revenue Next 3Y6.17%
Revenue Next 5Y6.56%
EBIT growth 1Y0.79%
EBIT growth 3Y7.77%
EBIT growth 5Y23.91%
EBIT Next Year27.21%
EBIT Next 3Y13.09%
EBIT Next 5Y11.23%
FCF growth 1Y-2.98%
FCF growth 3Y8.95%
FCF growth 5Y8.84%
OCF growth 1Y-2.28%
OCF growth 3Y5.5%
OCF growth 5Y6.26%

IQVIA HOLDINGS INC / QTS.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of IQVIA HOLDINGS INC (QTS.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to QTS.DE.


What is the valuation status for QTS stock?

ChartMill assigns a valuation rating of 6 / 10 to IQVIA HOLDINGS INC (QTS.DE). This can be considered as Fairly Valued.


How profitable is IQVIA HOLDINGS INC (QTS.DE) stock?

IQVIA HOLDINGS INC (QTS.DE) has a profitability rating of 6 / 10.


What is the financial health of IQVIA HOLDINGS INC (QTS.DE) stock?

The financial health rating of IQVIA HOLDINGS INC (QTS.DE) is 1 / 10.


Can you provide the expected EPS growth for QTS stock?

The Earnings per Share (EPS) of IQVIA HOLDINGS INC (QTS.DE) is expected to grow by 7.52% in the next year.